ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

15 Health Benefits of Chia Seeds, According to Science

Tangerine Oil: A Citrusy Essential Oil With Well-Rounded Uses

Natural Remedies for the Prevention of Dry Eyes

Magnesium Deficiency Raises Your Risk of Many Chronic Ailments

Resveratrol supplementation improves arterial stiffness in type 2 diabetics

CoQ10's Potential Capabilities for Your Health

How Can Melatonin Benefit You?

Cloves: Boost Your Immune System the Sweet and Spicy Way

8 Chia Seed Recipes

Testosterone replacement therapy associated with improved urinary, sexual function

 
Print Page
Email Article

Improved Awareness of Fibromyalgia by Both Physicians and Patients Will Drive the Drug Market, According to a New Study from Decision Resources

  [ 348 votes ]   [ Discuss This Article ]
www.ProHealth.com • June 21, 2005


Tuesday June 21, 8:00 am ET Although the Fibromyalgia Market Will More Than Triple in Size Over the Next Decade, it Will Remain Small in Comparison with Primary Target Markets Such As Depression, Neuropathic Pain, and Insomnia WALTHAM, Mass., June 21 /PRNewswire/ -- Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and health care issues, finds that improved awareness of fibromyalgia among both physicians and patients will be a major market driver over the next ten years. Currently, less than 20% of fibromyalgia sufferers receive an accurate diagnosis. "Reasons for low diagnosis of fibromyalgia include an absence of official diagnostic and treatment guidelines, a paucity of effective therapies, and continuing reticence on the part of many physicians to recognize fibromyalgia as a true syndrome in its own right," said Tricia Nagle, analyst at Decision Resources, Inc. "We expect notable improvements in diagnosis over the next ten years as a result of the publication of official treatment (and possibly diagnostic) guidelines and the approval of several new drug therapies to treat the condition. New drug approvals will not only help to validate fibromyalgia syndrome in the minds of physicians, but will also bring about a new era of drug marketing." The new Pharmacor study entitled Fibromyalgia also finds that, although the fibromyalgia market has clear potential, it remains a secondary target for most drug companies. Primary markets such as depression, neuropathic pain, or insomnia represent much more lucrative target markets than fibromyalgia, so many companies will investigate their drugs for fibromyalgia only after they have secured a place in one of the more lucrative markets. About Fibromyalgia Fibromyalgia is one of the most common diagnoses made in rheumatological practice, yet the causes of this condition remain unknown and the treatments remain largely ineffective. Indeed, no drugs are yet labeled to treat fibromyalgia in any of the major pharmaceutical markets (United States, France, Germany, Italy, Spain, United Kingdom, and Japan). About Pharmacor from Decision Resources Pharmacor is a unique family of studies that assesses a host of market- impacting factors and analyzes the commercial outlook for drugs in research and development. About Decision Resources Decision Resources, Inc., (http://www.decisionresources.com) is a world leader in market research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets. All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders. For more information, contact: Elizabeth Marshall Decision Resources, Inc. 781-296-2563 emarshall@dresources.com



Post a Comment

Featured Products From the ProHealth Store
Optimized Curcumin Longvida® Ultra EPA  - Fish Oil Ultra ATP+, Double Strength


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

Vitamin K-2 – A Key Player in Cardiovascular and Bone Health Vitamin K-2 – A Key Player in Cardiovascular and Bone Health
Astaxanthin - A Little-Known but Power-Packed Nutrient Astaxanthin - A Little-Known but Power-Packed Nutrient
Repair Damaged Mitochondria and Reduce Fatigue Up to 45% Repair Damaged Mitochondria and Reduce Fatigue Up to 45%
Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue
Natural Support for Mood, Sleep and Mental Focus? L-theanine Natural Support for Mood, Sleep and Mental Focus? L-theanine

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map